Viewing Study NCT00089492


Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2026-01-07 @ 6:02 AM
Study NCT ID: NCT00089492
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2004-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module